Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination refers to the co-administration or sequential use of isotonic saline (0.9% sodium chloride), hypertonic saline (typically 3% or 7.5% sodium chloride), and Ringer's lactate solution. These crystalloid fluids are primarily used for volume expansion, fluid resuscitation, and electrolyte replacement in clinical settings such as hemorrhagic shock, trauma, and major surgery. Isotonic saline and Ringer's lactate are standard maintenance and resuscitation fluids, while hypertonic saline is utilized to rapidly expand intravascular volume or manage intracranial pressure by creating an osmotic gradient that shifts water into the intravascular space. The combination is often studied in the context of optimizing fluid resuscitation strategies to improve hemodynamic stability and reduce complications like tissue edema.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isotonic saline + hypertonic saline + ringer lactate.